Finance

Beta
Ask
Lists
ALB:NYSE
Albemarle Corp
$149.98
-4.28%
(-6.71) 1D
$150.00
+0.01% (+0.020)
After hours
Closed: Jun 23, 4:00:10 PM GMT-4  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for ALB...
Open
$150.23
High
$152.94
Low
$149.00
Mkt. cap
17.69B
Avg. vol.
2.30M
Volume
1.95M
Dividend
1.08%
Quarterly dividend
$0.40
Ex-dividend date
Jun 12, 2026
52-wk high
$221.00
52-wk low
$58.60
EPS
-$3.41
Beta
1.30
Shares outstanding
117.94M
No. of employees
8K
Open
$150.23
High
$152.94
Low
$149.00
Mkt. cap
17.69B
Avg. vol.
2.30M
Volume
1.95M
Dividend
1.08%
Quarterly dividend
$0.40
Ex-dividend date
Jun 12, 2026
52-wk high
$221.00
52-wk low
$58.60
EPS
-$3.41
Beta
1.30
Shares outstanding
117.94M
No. of employees
8K
News stories
From sources across the web
Profile
Albemarle Corporation is an American specialty chemicals manufacturing company based in Charlotte, North Carolina. It serves several different industries including Agriculture/Food, Automotive/EV, Aviation/Aerospace, Building/Construction, Conventional Energy, Electronics, Grid Storage, and Industrial Processes. The company reported over $5.4 Billion in revenue in 2024. As of April 2025, Albemarle was the fourth highest grossing producer of Lithium, falling behind Rio Tinto, Sociedad Química y Minera, and Ganfeng Lithium. Albemarle is a large developer of flame retardant chemicals technologies, with production plants in the United States, China, the Netherlands, Belgium, Germany, France, Austria, and the United Kingdom. It also has a line of antioxidants and blends which concentrate on improving storage life and stability of fuel and other lubricant products. It produces products used in rigid and flexible polyurethane foam applications and ammonium polyphosphate products, pigments for paper applications, aluminium oxides used for flame-retardant, polishing, catalyst, and niche ceramic applications, as well as magnesium hydroxide mainly used as a flame-retardant. Wikipedia
About Albemarle Corp
CEOJ Kent Masters
Employees7.8K
FoundedFeb 28, 1994
Headquarters-
SectorSpeciality chemicals
Websitealbemarle.com
Analyst Ratings
Based on 18 analysts giving stock ratings to ALB in the past 3 months
Buy
Buy
10
Hold
8
Sell
0
12 month forecast
Based on 18 Wall Street analysts offering 12 month price targets for ALB in the last 3 months.
Highest
Current $149.98
$264.00 (+76.02%)
Average
$217.89 (+45.28%)
Lowest
$160.00 (+6.68%)
Analyst
Recommendation
Action
Price Target
Projected
Date
Jeffrey Zekauskas
J.P. Morgan
Hold
Maintained
$160.00
+6.7%
06/22/2026
Patrick Cunningham
Citi
Buy
Upgraded
$225.00
+50%
06/18/2026
Michael Sison
Wells Fargo
Hold
Reiterated
$200.00
+33.4%
06/04/2026
Andres Castanos-Mollor
Berenberg Bank
Hold
Maintained
$192.00
+28%
06/02/2026
Arun Viswanathan
RBC Capital
Buy
Maintained
$257.00
+71.4%
05/25/2026
Kevin McCarthy
Vertical Research
Buy
Upgraded
$224.00
+49.4%
05/26/2026
Ben Isaacson
Scotiabank
Buy
Maintained
$215.00
+43.4%
05/14/2026
David Begleiter
Deutsche Bank
Buy
Maintained
$250.00
+66.7%
05/12/2026
Vincent Andrews
Morgan Stanley
Hold
Maintained
$189.00
+26%
05/12/2026
Bill Selesky
Argus Research
Buy
Reiterated
$230.00
+53.4%
05/11/2026
Joshua Spector
UBS
Buy
Maintained
$264.00
+76%
05/08/2026
Eric Boyes
Evercore ISI
Hold
Maintained
$180.00
+20%
05/08/2026
Ben Kallo
Robert W. Baird
Hold
Maintained
$236.00
+57.4%
05/08/2026
Pete Osterland
Truist Financial
Buy
Maintained
$260.00
+73.4%
05/08/2026
John Roberts CFA
Mizuho Securities
Hold
Maintained
$205.00
+36.7%
05/06/2026
Mazahir Mammadli
Rothschild & Co Redburn
Hold
Downgraded
$188.00
+25.4%
04/22/2026
Rock Hoffman
Bank of America Securities
Buy
Reiterated
$225.00
+50%
04/21/2026
Colin Rusch
Oppenheimer
Buy
Reiterated
$222.00
+48%
04/13/2026
Laurence Alexander
Jefferies
Buy
Maintained
$230.00
+53.4%
02/11/2026
Last report
May 7, 2026
Fiscal period
Q1 2026
EPS / Est. (USD)
$2.95 / $1.31
+124.60%beat
Revenue / Est. (USD)
1.43B / 1.32B
+8.45%beat
Fiscal Q1 2026 earnings call
Waiting for the earnings call
At a glance
Insights from the latest news and reports
Previous reportsAll values in USD
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in USD
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Revenue
1.33B
1.31B
1.43B
1.43B
Cost of goods sold
1.13B
1.19B
1.23B
927.76M
Cost of revenue
1.13B
1.19B
1.23B
927.76M
Research and development expenses
12.44M
12.67M
12.18M
9.17M
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
129.24M
133.78M
158.24M
137.67M
Operating expense
141.69M
146.46M
170.42M
146.84M
Total operating expenses
1.27B
1.34B
1.40B
1.07B
Operating income
55.19M
-28.84M
32.31M
354.13M
Other non operating income
-90.93M
39.88M
179.27M
76.45M
EBT including unusual items
69.29M
-178.51M
-244.43M
350.49M
EBT excluding unusual items
115.02M
1.54M
37.70M
465.38M
Income tax expense
34.09M
-30.56M
157.33M
21.51M
Effective tax rate
49.21%
17.12%
-64.37%
6.14%
Other operating expenses
-
-
-
-
Net income
22.90M
-160.69M
-414.18M
319.09M
Net profit margin
1.72%
-12.29%
-29.00%
22.33%
Earnings per share
0.11
-0.19
-0.53
2.95
Interest and investment income
10.10M
-
-
-
Interest expense
-49.94M
-50.96M
-50.30M
-45.71M
Net interest expenses
-39.84M
-50.96M
-50.30M
-45.71M
Depreciation and amortization charges
-
-
-
-
EBITDA
223.92M
135.64M
196.02M
511.94M
Gain or loss from assets sale
-
-
-
95.02M
Insider transactions
Insider transactions data is drawn from third-party sources. Learn more
Insider
Position
Type
Date
Shares
Amount
Page 1
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer